| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/03/2009 | WO2009107387A1 2-oxochromene derivative |
| 09/03/2009 | WO2009107322A1 Pharmaceutical composition for treatment of cancer |
| 09/03/2009 | WO2009107262A1 Anticancer composition containing 3”-methylated epigallocatechin gallate |
| 09/03/2009 | WO2009107223A1 Method of producing ceramide |
| 09/03/2009 | WO2009106997A2 Amorphous arformoterol l-(+)-tartrate |
| 09/03/2009 | WO2009106986A2 Nonstructural protein ns1 as a novel therapeutic target against flaviviruses: use of inhibiting molecules interfering with ns1 maturation or biological activity |
| 09/03/2009 | WO2009106982A1 Indazole derivatives |
| 09/03/2009 | WO2009106980A2 Indazole derivatives |
| 09/03/2009 | WO2009106967A1 Novel 7-substituted derivatives of 3-carboxy-oxadiazino-quinolones, preparation thereof and use thereof as anti-bacterial agents |
| 09/03/2009 | WO2009106960A2 Stable compositions of lamivudine, tenofovir and efavirenz |
| 09/03/2009 | WO2009106954A1 Stable dosage forms of lamivudine and tenofovir |
| 09/03/2009 | WO2009106894A1 Novel crystalline forms |
| 09/03/2009 | WO2009106885A1 Heterocyclic urea derivatives and methods of use thereof-211 |
| 09/03/2009 | WO2009106850A1 Anti-oxidants for use for the treatment of damage to bodily tissue |
| 09/03/2009 | WO2009106844A1 Inhibitors of p38 map kinase |
| 09/03/2009 | WO2009106839A1 Use of tiamulin as an antiviral agent |
| 09/03/2009 | WO2009106831A2 Pharmaceutical composition |
| 09/03/2009 | WO2009106825A1 Polymorphs of sorafenib and salts thereof |
| 09/03/2009 | WO2009106824A2 Pharmaceutical formulations |
| 09/03/2009 | WO2009106817A2 Compound |
| 09/03/2009 | WO2009106769A1 5-[1'-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h-cyclopropa[a]naphtalen-4-yl)-3'-methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicarboxaldehyde used as drugs |
| 09/03/2009 | WO2009106767A2 Use of a homeoprotein of the bicoid family for preventing or treating retinal ganglionic neurone degeneration |
| 09/03/2009 | WO2009106753A1 Novel derivatives of 1h-indol-1-yl urea, method for preparing same and pharmaceutical compositions containing same |
| 09/03/2009 | WO2009106752A2 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106751A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106750A2 Derivatives of 6-heterocyclic-imidazo[l,2-a]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106749A2 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106748A2 Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106714A2 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock animals |
| 09/03/2009 | WO2009106708A2 Azetidine derivatives, their preparation and their application in therapy |
| 09/03/2009 | WO2009106640A2 N-benzyl imidazole derivatives |
| 09/03/2009 | WO2009106624A1 Anticancer agent |
| 09/03/2009 | WO2009106599A2 Substituted piperidines as therapeutic compounds |
| 09/03/2009 | WO2009106597A1 Use of lhrh antagonists at non-castrating doses |
| 09/03/2009 | WO2009106586A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase |
| 09/03/2009 | WO2009106577A1 Imidazo [1,2-b] pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease |
| 09/03/2009 | WO2009106574A2 Combinations for treating hiv-associated pain |
| 09/03/2009 | WO2009106565A1 Agonists of gpr119 |
| 09/03/2009 | WO2009106561A1 Pyrazine compounds for treating gpr119 related disorders |
| 09/03/2009 | WO2009106559A1 Uses of indane compounds |
| 09/03/2009 | WO2009106558A1 Mixed aqueous solution of l-lysine and l-threonine |
| 09/03/2009 | WO2009106555A2 Sterilized sucralfate gel |
| 09/03/2009 | WO2009106539A1 Heterocyclic compounds as inhibitors of cxcr2 |
| 09/03/2009 | WO2009106534A1 Novel heterocyclic carboxamides as m1 agonists |
| 09/03/2009 | WO2009106531A1 Pyrrolopyrimidinecarboxamides |
| 09/03/2009 | WO2009106516A1 Compositions, kits and methods for a titration schedule for pardoprunox compounds |
| 09/03/2009 | WO2009106502A2 Implant and method for the manufacture thereof |
| 09/03/2009 | WO2009106477A1 Microrna (mirna) and down-stream targets for diagnostic and therapeutic purposes |
| 09/03/2009 | WO2009106445A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009106444A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009106443A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009106442A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009106441A1 Pyrrolopyrazine kinase inhibitors |
| 09/03/2009 | WO2009106419A1 New macrolides and their use |
| 09/03/2009 | WO2009106367A1 Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes |
| 09/03/2009 | WO2009106351A1 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the b2 adrenergic receptor |
| 09/03/2009 | WO2009106333A1 Nanosuspension with antifungal medication to be administered via inhalation with improved impurity profile and safety |
| 09/03/2009 | WO2009106307A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain |
| 09/03/2009 | WO2009106302A1 Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 09/03/2009 | WO2009106211A1 Beta-lactones as antibacterial agents |
| 09/03/2009 | WO2009106203A1 Glucokinase activators |
| 09/03/2009 | WO2009106125A1 Polyphenols for the treatment of cartilage disorders |
| 09/03/2009 | WO2009106087A1 Drug for dermal use for treating dermatophysis |
| 09/03/2009 | WO2009105969A1 Epothilone analogues, their pharmaceutical compositions, their use and their preparations |
| 09/03/2009 | WO2009105937A1 A vinorelbine soft capsule and its preparation method and application. |
| 09/03/2009 | WO2009105936A1 The use of phenolic glycosides derivatives in the manufacture of compositions for treating cell proliferation diseases |
| 09/03/2009 | WO2009105897A1 Polyhydroxylated bile acids for treatment of biliary disorders |
| 09/03/2009 | WO2009105887A1 Cyclic amino acids for the treatment of pain |
| 09/03/2009 | WO2009105874A1 Composition and method for irrigation of a prepared dental root canal |
| 09/03/2009 | WO2009105853A2 Pharmaceutical composition |
| 09/03/2009 | WO2009105825A1 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 09/03/2009 | WO2009105824A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor |
| 09/03/2009 | WO2009105823A1 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
| 09/03/2009 | WO2009089383A3 Inhibitors of carbonic anhydrase ix |
| 09/03/2009 | WO2009089365A3 Therapeutic formulations based on asiatic acid and selected salts thereof |
| 09/03/2009 | WO2009089011A3 Resveratrol formulations |
| 09/03/2009 | WO2009087474A3 Agonists for antimicrobial peptide systems |
| 09/03/2009 | WO2009087379A3 Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases |
| 09/03/2009 | WO2009086526A3 Methods for enhancing muscle performance and tone |
| 09/03/2009 | WO2009085198A3 Combination of metformin r-(+)-lipoate and antiobesity agents for the treatment of diabetic hyperglycemia and diabetic complications |
| 09/03/2009 | WO2009082818A8 Novel c-21-keto lupane derivatives preparation and use thereof |
| 09/03/2009 | WO2009082437A3 Selective androgen receptor modulators (sarms) and uses thereof |
| 09/03/2009 | WO2009082363A8 Method and preparations for treating infection-allergic diseases |
| 09/03/2009 | WO2009081246A3 Bicyclic diamines as nicotinic receptor agonists |
| 09/03/2009 | WO2009077187A3 Compositon for enhancing immunity |
| 09/03/2009 | WO2009076408A3 3 -carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists |
| 09/03/2009 | WO2009076397A9 Antiviral activity of cyclopentene nitro-ester and derivatives |
| 09/03/2009 | WO2009076234A3 Synthesis methods of histone deacetylase inhibitors (hdacis) |
| 09/03/2009 | WO2009073683A3 Methods of treating copd |
| 09/03/2009 | WO2009070045A3 Imidazole derivatives, process for their preparation, and thier pharmaceutical use |
| 09/03/2009 | WO2009067703A3 Tapentadol compositions |
| 09/03/2009 | WO2009067543A3 Treatment of histone deacetylase mediated disorders |
| 09/03/2009 | WO2009064590A3 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer |
| 09/03/2009 | WO2009063492A9 Novel agents for treatment of ailments and dysfunctions |
| 09/03/2009 | WO2009062676A3 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 09/03/2009 | WO2009059748A3 Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations |
| 09/03/2009 | WO2009059717A3 Pharmaceutical compositions containing statins and omega-3 fatty acids derivatives and their solid formulations for oral use |
| 09/03/2009 | WO2009058937A3 Heteroaryl ethers and processes for their preparation |
| 09/03/2009 | WO2009056990A3 Paliperidone polymorphs |
| 09/03/2009 | WO2009053754A3 Novel crystalline forms |